Events

Cluster 6 - Commission Info days on 2023 call topics
DEC
Tue
13
DEC
Wed
14

This was 2 years ago

Location

Virtually

Programmes
Agro-Food, Environment

The Horizon Europe Cluster 6 Information Days are going to be held virtually on 13 and 14 December 2022.

At the Info Days the topics of the Cluster 6 2023 call topics will be presented. (Prospective) applicants will get the opportunity to familiarise with the new topics under the 2023 work programme and to raise questions. 

More information and registration on the Commission website.

The Commission Info Days will be followed by a Brokerage event on 19 December 2022, organised by the CARE4BIO project. This will complement the Info Days with an offer of networking and matchmaking opportunities to prospective applicants to support the building of proposals’ consortia.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.